Neuronetics has developed the NeuroStar TMS Therapy^® system, the first and only non-systemic and non-invasive TMS system for the treatment of depression. It was recently cleared by the U.S. Food and Drug Administration (FDA) for the treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from prior antidepressant medication.^* This non-invasive treatment for depression uses highly focused, pulsed magnetic field to stimulate function in targeted brain regions.

NeuroStar TMS Therapy is a 37-minute outpatient procedure that is available by prescription only and is performed under the supervision of a psychiatrist. It does not require anesthesia or sedation, and patients remain awake and alert during the procedure. Treatment is administered daily for four to six weeks (20-30 treatments).